rs199473171
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM1PM2PM5PP2PP3_StrongPP5
The NM_001099404.2(SCN5A):c.2677C>T(p.Arg893Cys) variant causes a missense change. The variant allele was found at a frequency of 0.00000496 in 1,613,994 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 13/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R893H) has been classified as Pathogenic.
Frequency
Consequence
NM_001099404.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SCN5A | NM_001099404.2 | c.2677C>T | p.Arg893Cys | missense_variant | 16/28 | ENST00000413689.6 | NP_001092874.1 | |
SCN5A | NM_000335.5 | c.2677C>T | p.Arg893Cys | missense_variant | 16/28 | ENST00000423572.7 | NP_000326.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCN5A | ENST00000413689.6 | c.2677C>T | p.Arg893Cys | missense_variant | 16/28 | 5 | NM_001099404.2 | ENSP00000410257 | P4 | |
SCN5A | ENST00000423572.7 | c.2677C>T | p.Arg893Cys | missense_variant | 16/28 | 1 | NM_000335.5 | ENSP00000398266 | A1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152178Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000399 AC: 1AN: 250888Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135812
GnomAD4 exome AF: 0.00000479 AC: 7AN: 1461816Hom.: 0 Cov.: 36 AF XY: 0.00000413 AC XY: 3AN XY: 727204
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152178Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74340
ClinVar
Submissions by phenotype
not provided Pathogenic:2Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Feb 01, 2024 | In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Not observed at significant frequency in large population cohorts (gnomAD); Published functional studies are equivocal regarding whether this variant has a damaging effect (PMID: 35305865, 34219138); This variant is associated with the following publications: (PMID: 22581653, 24136861, 28341781, 28150151, 30371189, 30662450, 35305865, 34219138, 35617207, 31737537, 30203441, 30193851, 20129283, 29574140, 35331424) - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 893 of the SCN5A protein (p.Arg893Cys). This variant is present in population databases (rs199473171, gnomAD 0.004%). This missense change has been observed in individuals with Brugada syndrome (PMID: 28341781, 29574140; Invitae). ClinVar contains an entry for this variant (Variation ID: 67748). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. This variant disrupts the p.Arg893 amino acid residue in SCN5A. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 23503384, 28341781; Invitae). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Clinical Genetics Laboratory, Skane University Hospital Lund | Mar 28, 2024 | - - |
Brugada syndrome 1 Pathogenic:2
Likely pathogenic, criteria provided, single submitter | research | HudsonAlpha Institute for Biotechnology, HudsonAlpha Institute for Biotechnology | - | ACMG codes: PM1; PM2; PM5; PP3 - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Center For Human Genetics And Laboratory Diagnostics, Dr. Klein, Dr. Rost And Colleagues | Mar 09, 2018 | - - |
Cardiovascular phenotype Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 15, 2024 | The p.R893C variant (also known as c.2677C>T), located in coding exon 15 of the SCN5A gene, results from a C to T substitution at nucleotide position 2677. The arginine at codon 893 is replaced by cysteine, an amino acid with highly dissimilar properties. This variant has been detected in individuals with type 1 Brugada syndrome (BrS) pattern on ECG, and has been detected in individuals from BrS cohorts or BrS genetic testing cohorts for whom clinical detail was limited (Kapplinger JD et al. Heart Rhythm, 2010 Jan;7:33-46; Aizawa Y et al. J Am Heart Assoc, 2018 Sep;7:e009387; Sonoda K et al. Heart Rhythm, 2018 Aug;15:1179-1188; Berthome P et al. Heart Rhythm, 2019 Feb;16:260-267; Ikeuchi Y et al. PLoS One, 2022 May;17:e0261390; Marschall C et al. Cardiovasc Diagn Ther, 2019 Oct;9:S292-S298). In in vitro assays testing SCN5A function, this variant showed functionally abnormal results in the mock-homozygous state, and functionally indeterminant results in the mock-heterozygous state (Ishikawa T et al. Eur Heart J, 2021 Jul;42:2854-2863; O'Neill MJ et al. Genet Med, 2022 Jun;24:1238-1248). Another alteration at the same codon, p.R893H (c.2678G>A), has also been described in association with BrS (Chinushi M et al. Pacing Clin Electrophysiol, 2011 Jan;34:e1-5). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic. - |
Cardiac arrhythmia Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | All of Us Research Program, National Institutes of Health | Dec 01, 2023 | - - |
Brugada syndrome Other:1
not provided, no classification provided | literature only | Cardiovascular Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust | - | This variant has been reported as associated with Brugada syndrome in the following publications (PMID:20129283). This is a literature report, and does not necessarily reflect the clinical interpretation of the Imperial College / Royal Brompton Cardiovascular Genetics laboratory. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at